Related Experiment Video
Updated: Aug 7, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
Ac-SDKP modulates apoptosis via HSP27 and the FAS/FASL and mitochondrial axes
Wenxin Guo1,2, Jinyin Yan3, Wenli Li1,2
1School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
Background:
Silicosis is a progressive, irreversible fibrotic lung disease caused by long-term exposure to crystalline silica. Although the anti-fibrotic tetrapeptide Ac-SDKP has shown promise in reducing fibrosis, the specific molecular mechanisms through which it modulates apoptosis in silica-induced lung injury remain unclear, particularly the role of heat shock protein 27 (HSP27).
Methods:
Wistar rats were divided into groups including control, model (2-week, 3-week, and 4-week), and Ac-SDKP prevention/treatment groups. In vitro, MEF and A549 cells were treated with TGF-β1 and Ac-SDKP to observe the effects on apoptosis-related proteins. Additionally, HSP27 interference vectors were constructed to study its role in regulating apoptosis via FAS/FASL and mitochondrial pathways in both in vivo and in vitro models.
Results:
In vivo, Ac-SDKP administration alleviated silica-induced pulmonary fibrosis and reduced apoptosis in lung tissue. In contrast, in vitro, TGF-β1 stimulation suppressed apoptosis in A549 and MEF cells, whereas Ac-SDKP restored apoptotic activity by regulating the HSP27-mediated FAS/FASL and mitochondrial pathways. Moreover, AAV9-mediated knockdown of HSP27 in mice enhanced apoptosis and attenuated fibrosis, confirming the anti-apoptotic role of HSP27 in silicosis.
Conclusion:
These findings reveal that Ac-SDKP exerts context-dependent modulation of apoptosis through HSP27-protecting acutely injured alveolar epithelial cells in vivo while reinstating apoptotic signaling in EMT-adapted A549 and MEF cells in vitro. Thus, targeting HSP27 may offer a promising therapeutic strategy to restore apoptotic-fibrotic equilibrium in silicosis and related pulmonary fibrotic disorders.
Insights
The anti-fibrotic tetrapeptide Ac-SDKP modulates apoptosis via heat shock protein 27 (HSP27) in silicosis. Targeting HSP27 may restore apoptotic-fibrotic balance in lung fibrosis.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Fibrotic Lung Disease Research
Background:
- Silicosis is a progressive lung fibrosis from crystalline silica exposure.
- The anti-fibrotic tetrapeptide Ac-SDKP shows therapeutic potential.
- Mechanisms of Ac-SDKP in silica-induced lung injury, particularly HSP27's role in apoptosis, require clarification.
Purpose of the Study:
- Investigate Ac-SDKP's modulation of apoptosis in silicosis.
- Elucidate the role of heat shock protein 27 (HSP27) in this process.
- Explore therapeutic strategies targeting HSP27 for pulmonary fibrosis.
Main Methods:
- In vivo studies using Wistar rats with silica exposure, treated with Ac-SDKP.
- In vitro experiments with MEF and A549 cells treated with TGF-β1 and Ac-SDKP.
- Utilized HSP27 interference vectors to assess apoptosis pathways (FAS/FASL, mitochondrial).
Main Results:
- Ac-SDKP alleviated pulmonary fibrosis and reduced apoptosis in vivo.
- In vitro, Ac-SDKP restored apoptosis suppressed by TGF-β1 via HSP27-mediated pathways.
- HSP27 knockdown enhanced apoptosis and reduced fibrosis in vivo, confirming its anti-apoptotic role.
Conclusions:
- Ac-SDKP context-dependently modulates apoptosis via HSP27.
- HSP27 protects lung cells in vivo but promotes survival in vitro.
- Targeting HSP27 offers a potential therapeutic strategy for silicosis and related fibrotic disorders.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Caspases
Apoptosis
MAPK Signaling Cascades
Cellular Injury V: Apoptosis and Autophagy

